Spyre Therapeutics, Inc. SYRE Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s prepaid & other current?
- Spyre Therapeutics, Inc. (SYRE) reported prepaid & other current of $22.49M in Q1 2026.
- How has Spyre Therapeutics, Inc.'s prepaid & other current changed year-over-year?
- Spyre Therapeutics, Inc.'s prepaid & other current increased by 354.4% year-over-year, from $4.95M to $22.49M.
- What is the long-term trend for Spyre Therapeutics, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Spyre Therapeutics, Inc.'s prepaid & other current has grown at a 43.3% compound annual growth rate (CAGR), from $3.52M to $21.25M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.